Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Innovation in adjuvant radiotherapy for breast cancer: new biologic parameters, a perspective for treatment tailoring].

Bulletin du cancer - 1 Jan 2009

Belkacémi Y

Abstract excerpt

In the adjuvant setting, whole breast radiation therapy (RT) delivering 50 Gy in 5 weeks with or without a boost to the tumor bed remains the standard of care. RT indications and volume definition are generally dependant on existing prognostic factors. Except in particular cases, RT technique does not vary according to the patient or tumor biology profiles in terms of total dose, dose per fraction, fractionation,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, erbB-2
Share to Membrane Transport Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Protozoan Proteins

Share to Radiation Tolerance

Share to Radiotherapy, Adjuvant

Share to Radiotherapy Dosage

Source

Identifiers

PMID: 19211366
DOI: 10.1684/bdc.2009.0800

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Innovation in adjuvant radiotherapy for breast cancer: new biologic parameters, a perspective for treatment tailoring].PMID 19211366Read ↗

Breast Cancer Adjuvant Radiotherapy and Chemotherapy Sequencing: Sequential, Concomitant, or What Else? A Comprehensive Review on the Adjuvant Combinations JourneySemantic proximity Read ↗

[Genetic bases of the radiosensitivity of breast cancer].Semantic proximity Read ↗

The new millennium for adjuvant therapy in breast cancer.Semantic proximity Read ↗

[Therapeutic implications of advances in breast cancer biology].Semantic proximity Read ↗

[Precision medicine and immuno-radiotherapy].Semantic proximity Read ↗

[Biochemical markers predicting response to radiation- and radiochemo-therapy in cancer patients].Semantic proximity Read ↗

Radiation therapy in the locoregional treatment of triple-negative breast cancer.Semantic proximity Read ↗

Interim Analysis of Dose-Escalated Preoperative Breast Irradiation: A Phase Ib studySemantic proximity Read ↗

[Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy].Semantic proximity Read ↗

Re-evaluating the Role of Regional Nodal Irradiation for Node‐Negative Breast Cancer in the Modern Therapy Era: A Matched Cohort Analysis of EORTC 22922/10925Semantic proximity Read ↗

Translating neoadjuvant therapy into survival benefits: one size does not fit all.Semantic proximity Read ↗

[Current molecular prognostic factors in breast carcinoma].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.